Stay updated with breaking news from Clinical Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
When the Covid-19 pandemic struck in early 2020, doctors and researchers rushed to find effective treatments. There was little time to spare.
4.2.3 Wellness Hurts 4.3 Diagnostic Technology Development 4.3.2 NAT vs. Lateral Flow 4.3.3 The Unusual Role of GPS 4.3.4 Self and Send Competition 4.4.5 The Relationship to DTC Genetic 4.4.6 The Relationship to TeleHealth 4.4.7 Sample Collection - Who Knew? 5. OTC/DTC Infectious Disease Testing Recent Developments Recent Developments - Importance and How to Use This Section Importance of These Developments Biohacking trend supports self testing. PerkinElmer and EverlyWell to Expand U.S. At-Home Health Test Market Mylan, Atomo Diagnostics Get WHO Prequalification Approval for HIV Self...
4.2.3 Wellness Hurts 4.3 Instrumentation and Automation 4.3.2 The Shrinking Machine. 4.4 Diagnostic Technology Development 4.4.2 POCT/Self Testing as a Disruptive Force 4.4.3 The Genetics Play - One Test for All Known Infections 4.4.4 Antibiotic Resistance Genes - Simplifying Diagnostics 5. Molecular Dx - Infectious Disease Recent Developments Recent Developments- Importance and How to Use This Section Importance of These Developments Fusion Genomics to Assess NGS-Based Respiratory Tract Infection Assay New Genomic Tests Diagnose Deadly Infections Faster Biotia Raises $2.4M Seed Round ...
Global Infectious Disease Molecular Diagnostics Markets Report 2021 - Multiplex Testing Threatens Existing Assays / Test Speed Taking Centre Stage. February 02, 2021 04:38 ET | Source: Research and Markets Research and Markets Dublin, IRELAND Multiplex testing threatens existing infectious disease practice. The microbiology lab may disappear. The Molecular Diagnostics - Infectious Disease sector of the clinical diagnostics industry is poised for record growth. A market that just keeps on growing. In spite of the steady decline of disease prevalenc...
A single genetic test can identify the presence and cause of mismatch repair deficiency Researchers have developed a new integrated genetic/epigenetic DNA-sequencing protocol known as MultiMMR that can identify the presence and cause of mismatch repair (MMR) deficiency in a single test from a small sample of DNA in colon, endometrial, and other cancers. This alternative to complex, multi-step testing workflows can also determine causes of MMR deficiency often missed by current clinical tests. Their results are presented in the Journal of Molecular Diagnostics, published by Elsevier. MMR gene...